• About the Journal

    Aims and Scope

    Exploration of Targeted Anti-tumor Therapy (eISSN 2692-3114), a peer-reviewed, open access online journal, publishes articles on all aspects of cancer research, including clinical diagnosis and analysis, case report, prevention, intervention treatment, pre-clinical and clinical trials of all types of cancers. Submissions with good originality, well-designed experiments and rigorous data are particularly welcomed. 

    Publication Frequency

    Exploration of Targeted Anti-tumor Therapy is a bimonthly journal and published in February, April, June, August, October, December. All accepted articles will be published "Online First" immediately after production, and will be officially published in a coming issue. Readers can access the content as quickly as possible, and the paper can be cited immediately.

    Open Access

    The journal provides immediate open access to all published content. Everyone can enjoy free and unrestricted use of these published content under the Creative Commons Attribution 4.0 International (CC BY) license. More information can be found at Open Access.

    Indexing

    Baiduxueshu

    CNKI Scholar (waiting for sync)

    Dimensions

    J-Gate

    MyScienceWork

    OUCI

    Portico

    ResearchGate

    ROAD

    Semantic Scholar

    The Keepers

    Peer Review

    The journal adopts a single-blind peer review. Except for some Editorials released by the Editors, all manuscripts will undergo a strict review to assess their novelty, validity and significance, etc. More information can be found at Peer Review and Peer Review Guidelines. For the whole editorial process, please refer to Editorial Process.

    Permanent Archive

    To ensure long-term digital preservation, all the published articles will be archived on Portico platform. Authors are encouraged to deposit their articles in PubMed Central and Europe PubMed Central, or other appropriate funding body's archive.

    Owner

    The journal is owned and published by Open Exploration.